Association of Neuropsychology Students in Training (ANST)
Follow us online!
  • Home
    • About ANST
    • ANST Leadership
    • FAQ/Contact Us
  • Membership & Interest Groups
    • Joining ANST
    • ANST Interest Groups
    • Starting an Interest Group
    • ANST Highlights
  • Training & Education
    • What's Neuropsychology?
    • Professional Definitions
    • Organizations to Know
  • ANST Media
    • ANST Blog
    • ANST Listserv
    • Webinars
    • Social Media
  • Resources
    • Conferences & Events
    • Funding
    • On the Web
    • Downloadable Materials

RESEARCH ROUNDUP: Catechol-O-methyltransferase (COMT) polymorphism and Cognition

10/20/2014

0 Comments

 
Picture

Catechol-O-methyltransferase (COMT) polymorphism and Cognition

Guest Contributor: Keenan Walker – St. John’s University, Clinical Psychology Program

Since the mapping of the human genome, a field called neuropsychiatric phenomics has emerged, which integrates genetic data with neurobiology and cognitive neuroscience. One single-nucleotide polymorphism (SNP) on chromosome 22 has received considerable attention over the last two decades for its role in cognition (i.e., the COMT Val158Met polymorphism). This COMT gene codes for the enzyme, catechol-o-methyltransferase, which plays a role in the clearance of catecholamines such as dopamine. The COMT enzyme is believed to be especially important for clearance of dopamine within the prefrontal cortex (PFC). Some individuals are born with COMT enzymes that slowly remove dopamine from the PFC (Val/Val homozygotes), and others with COMT enzymes that rapidly remove dopamine from the PFC (Met/Met homozygotes). Research comparing individuals with slow versus fast variants of the COMT gene has repeatedly demonstrated that people with the slow acting COMT enzyme have greater amounts of dopamine within the PFC. These individuals tend to perform better on cognitive measures, particularly measures which assess executive functioning. These findings have been replicated several times in neurologically normal children and adults, and in adult patients with schizophrenia.

 

WEBINAR: COMT and Schizophrenia
Professor Daniel Weinberger explains why the gene COMT, which catabolizes dopamine, is a candidate gene for schizophrenia.

LINK: http://www.dnalc.org/view/1168-COMT-and-Schizophrenia.html


ABSTRACT: Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects (2014)
The 22q11.2 deletion syndrome (22q11.2DS) carries the highest genetic risk factor for the development of schizophrenia. We investigated the association of genetic variants in two schizophrenia candidate genes with executive function (EF) and IQ in 22q11.2DS individuals. Ninety two individuals with 22q11.2 deletion were studied for the genetic association between COMT and PRODH variants and EF and IQ. Subjects were divided into children (under 12 years old), adolescents (between 12 and 18 years old) and adults (older than 18 years), and genotyped for the COMT Val158Met (rs4680) and PRODH Arg185Trp (rs4819756) polymorphisms. The participants underwent psychiatric evaluation and EF assessment. Our main finding is a significant influence of the COMT Val158Met polymorphism on both IQ and EF performance. Specifically, 22q11.2DS subjects with Met allele displayed higher IQ scores in all age groups compared to Val carriers, reaching significance in both adolescents and adults. The Met allele carriers performed better than Val carriers in EF tasks, being statistically significant in the adult group. PRODH Arg185Trp variant did not affect IQ or EF in our 22q11.2DS cohort. In conclusion, functional COMT variant, but not PRODH, affects IQ and EF in 22q11.2DS subjects during neurodevelopment with a maximal effect at adulthood. Future studies should monitor the cognitive performance of the same individuals from childhood to old age.

Carmel, M., Zarchi, O., Michaelovsky, E., Frisch, A., Patya, M., Green, T., Gothelf, D., & Weizman, A. (2014) Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects. J Psychiatr Res, 56, 28-35. doi: 10.1016/j.jpsychires.2014.04.019.

LINK: http://www.ncbi.nlm.nih.gov/pubmed/24853458
 

FURTHER READING:
Bilder, R. M., Volavka, J., Lachman, H. M., & Grace, A. a. (2004). The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 29(11), 1943–61. doi:10.1038/sj.npp.1300542

LINK: http://www.ncbi.nlm.nih.gov/pubmed/15305167


Nolan, K. A., Bilder, R. M., Lachman, H. M., & Volavka, J. (2004). Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. The American journal of psychiatry, 161(2), 359–61. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14754787

LINK: http://www.ncbi.nlm.nih.gov/pubmed/14754787

 
Yeh, T., Chang, C., Hu, C., Yeh, T., & Lin, M. (2009). Association of catechol-O-methyltransferase (COMT) polymorphism and academic achievement in a Chinese cohort. Brain Cogn, 3, 300-5. doi: 10.1016/j.bandc.2009.07.011.

LINK: http://www.ncbi.nlm.nih.gov/pubmed/19700233

About the contributor:

Keenan Walker attends the Clinical Psychology Program at St. John’s University.
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    RSS Feed

    An RSS Feed lets you subscribe to this blog series, and you'll receive notifications whenever a new addition is posted.
    

    Archives

    July 2018
    May 2018
    April 2018
    March 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    May 2017
    April 2017
    March 2017
    August 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013


    Categories

    All
    ANST Director's Meeting
    Chapter Rep Corner
    Neurorounds
    NPsych In The Media
    Research Roundup


    Other Blogs/Podcasts

    SCN NeuroBlog

    BrainBlogger

    Neurophilosophy


    Brain Science Podcast

    Neuropod

    Neuroscientists Talk Shop

    gradPSYCH Blog

Powered by Create your own unique website with customizable templates.